With 0.66 million shares changed hands, the volume of the stock remained lighter than its average volume of 8.11 million shares. During the session, the Medical Devices company that operates in wider Healthcare sector, reached to the highest price of $0.4299 whereas the lowest price it dropped to was $0.4. The 52-week range on PFSA shows that it touched its highest point at $12.76 and its lowest point at $0.38 during that stretch.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of PFSA was down-trending over the past week, with a drop of -18.00%, but this was down by -41.43% over a month. Three-month performance dropped to -96.40% while six-month performance fell -96.21%. The stock lost -96.50% in the past year, while it has lost -95.90% so far this year.
Float and Shares Shorts:
On 2025-08-15, short shares totaled 0.26 million, which was 80.0 higher than short shares on 1752537600. In addition to Mr. William McMillan as the firm’s Co-founder, Chief Scientific Officer & Head of Research, Mr. Fred S. Knechtel serves as its CFO & Director.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-06-30, PFSA reported revenue of $0.0 and operating income of -$967084.0. The EBITDA in the recently reported quarter was $4950361.0 and diluted EPS was -$0.24999.
